172 related articles for article (PubMed ID: 30243024)
61. Lack of exon 10 in the murine tau gene results in mild sensorimotor defects with aging.
Gumucio A; Lannfelt L; Nilsson LN
BMC Neurosci; 2013 Nov; 14():148. PubMed ID: 24261309
[TBL] [Abstract][Full Text] [Related]
62. Novel isoforms of tau that lack the microtubule-binding domain.
Luo MH; Tse SW; Memmott J; Andreadis A
J Neurochem; 2004 Jul; 90(2):340-51. PubMed ID: 15228591
[TBL] [Abstract][Full Text] [Related]
63. Complex splicing and neural expression of duplicated tau genes in zebrafish embryos.
Chen M; Martins RN; Lardelli M
J Alzheimers Dis; 2009; 18(2):305-17. PubMed ID: 19584432
[TBL] [Abstract][Full Text] [Related]
64. Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome.
Shi J; Zhang T; Zhou C; Chohan MO; Gu X; Wegiel J; Zhou J; Hwang YW; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F
J Biol Chem; 2008 Oct; 283(42):28660-9. PubMed ID: 18658135
[TBL] [Abstract][Full Text] [Related]
65. High-fat diet increases tau expression in the brain of T2DM and AD mice independently of peripheral metabolic status.
Takalo M; Haapasalo A; Martiskainen H; Kurkinen KM; Koivisto H; Miettinen P; Khandelwal VK; Kemppainen S; Kaminska D; Mäkinen P; Leinonen V; Pihlajamäki J; Soininen H; Laakso M; Tanila H; Hiltunen M
J Nutr Biochem; 2014 Jun; 25(6):634-41. PubMed ID: 24746833
[TBL] [Abstract][Full Text] [Related]
66. Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2.
Carpentier C; Ghanem D; Fernandez-Gomez FJ; Jumeau F; Philippe JV; Freyermuth F; Labudeck A; Eddarkaoui S; Dhaenens CM; Holt I; Behm-Ansmant I; Marmier-Gourrier N; Branlant C; Charlet-Berguerand N; Marie J; Schraen-Maschke S; Buée L; Sergeant N; Caillet-Boudin ML
Biochim Biophys Acta; 2014 Apr; 1842(4):654-64. PubMed ID: 24440524
[TBL] [Abstract][Full Text] [Related]
67. Hypoxic ischemia and proteasome dysfunction alter tau isoform ratio by inhibiting exon 10 splicing.
Suh J; Im DS; Moon GJ; Ryu KS; de Silva R; Choi IS; Lees AJ; Guénette SY; Tanzi RE; Gwag BJ
J Neurochem; 2010 Jul; 114(1):160-70. PubMed ID: 20374429
[TBL] [Abstract][Full Text] [Related]
68. [Visualization of tau isoforms by splicing-site specific antibodies].
Mori H
Rinsho Shinkeigaku; 2001 Dec; 41(12):1104-6. PubMed ID: 12235809
[TBL] [Abstract][Full Text] [Related]
69. Modulation of the membrane-binding projection domain of tau protein: splicing regulation of exon 3.
Arikan MC; Memmott J; Broderick JA; Lafyatis R; Screaton G; Stamm S; Andreadis A
Brain Res Mol Brain Res; 2002 May; 101(1-2):109-21. PubMed ID: 12007838
[TBL] [Abstract][Full Text] [Related]
70. Protein Phosphatase 1 dephosphorylates TDP-43 and suppresses its function in tau exon 10 inclusion.
Gu J; Wang W; Miao S; Chen F; Wu F; Hu W; Iqbal K; Gong CX; Liu F
FEBS Lett; 2018 Feb; 592(3):402-410. PubMed ID: 29334120
[TBL] [Abstract][Full Text] [Related]
71. ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I.
Leroy O; Dhaenens CM; Schraen-Maschke S; Belarbi K; Delacourte A; Andreadis A; Sablonnière B; Buée L; Sergeant N; Caillet-Boudin ML
J Neurosci Res; 2006 Sep; 84(4):852-9. PubMed ID: 16862542
[TBL] [Abstract][Full Text] [Related]
72. The DeltaK280 mutation in MAP tau favors exon 10 skipping in vivo.
van Swieten JC; Bronner IF; Azmani A; Severijnen LA; Kamphorst W; Ravid R; Rizzu P; Willemsen R; Heutink P
J Neuropathol Exp Neurol; 2007 Jan; 66(1):17-25. PubMed ID: 17204933
[TBL] [Abstract][Full Text] [Related]
73. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
Kowalska A
Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
[TBL] [Abstract][Full Text] [Related]
74. Mitochondrial complex 1 inhibition increases 4-repeat isoform tau by SRSF2 upregulation.
Bruch J; Xu H; De Andrade A; Höglinger G
PLoS One; 2014; 9(11):e113070. PubMed ID: 25402454
[TBL] [Abstract][Full Text] [Related]
75. Modulation of the membrane-binding domain of tau protein: splicing regulation of exon 2.
Li K; Arikan MC; Andreadis A
Brain Res Mol Brain Res; 2003 Aug; 116(1-2):94-105. PubMed ID: 12941465
[TBL] [Abstract][Full Text] [Related]
76. Neuroprotective Mechanisms of Resveratrol in Alzheimer's Disease: Role of SIRT1.
Gomes BAQ; Silva JPB; Romeiro CFR; Dos Santos SM; Rodrigues CA; Gonçalves PR; Sakai JT; Mendes PFS; Varela ELP; Monteiro MC
Oxid Med Cell Longev; 2018; 2018():8152373. PubMed ID: 30510627
[TBL] [Abstract][Full Text] [Related]
77. Heterogeneous nuclear ribonucleoprotein E2 binds to tau exon 10 and moderately activates its splicing.
Broderick J; Wang J; Andreadis A
Gene; 2004 Apr; 331():107-14. PubMed ID: 15094196
[TBL] [Abstract][Full Text] [Related]
78. SIRT1 Regulates Tau Expression and Tau Synaptic Pathology.
Yin X; Zhou Z; Qiu Y; Fan X; Zhao C; Bao J; Liu C; Liu F; Qian W
J Alzheimers Dis; 2021; 84(2):895-904. PubMed ID: 34602486
[TBL] [Abstract][Full Text] [Related]
79. Splicing of a regulated exon reveals additional complexity in the axonal microtubule-associated protein tau.
Wei ML; Andreadis A
J Neurochem; 1998 Apr; 70(4):1346-56. PubMed ID: 9523550
[TBL] [Abstract][Full Text] [Related]
80. Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease.
Boutajangout A; Boom A; Leroy K; Brion JP
FEBS Lett; 2004 Oct; 576(1-2):183-9. PubMed ID: 15474035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
